Insider Transactions Reported by 15 Insiders of Tricida, Inc.

Location
South San Francisco, CA

Ownership snapshot

Top shareholders of Tricida, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.

Lead holder
Brian M. Isern
13D/G signal
Evidence rows
12
Latest as of
24 Oct 2022
3/4/5 Some rows are evidence-backed but not safely comparable across classes.
Holder Evidence Ownership % Position 12M Net Δ As of
Brian M. Isern
3/4/5
*possible member of 10% group, 10%+ Owner
class O/S missing
5,563,493 shares
11 Oct 2022
Venrock Healthcare Capital Partners II, L.P.
3/4/5
10%+ Owner
class O/S missing
3,751,406 shares
24 Oct 2022
Sandra I. Coufal
3/4/5
Director, 10%+ Owner
class O/S missing
27,207 shares
15 Jun 2022
Gerrit Klaerner
3/4/5
President and CEO, Director
class O/S missing
511,000 shares
28 Feb 2022
Dawn Parsell Otto
3/4/5
EVP, Clinical Development
class O/S missing
256,000 shares
28 Feb 2022
Mr. Geoffrey Parker
3/4/5
COO, CFO and EVP
class O/S missing
256,000 shares
28 Feb 2022
Robert McKague
3/4/5
EVP, General Counsel
class O/S missing
256,000 shares
28 Feb 2022
David Hirsch
3/4/5
Director
class O/S missing
27,207 shares
15 Jun 2022
Kathryn E. Falberg
3/4/5
Director
class O/S missing
27,207 shares
15 Jun 2022
Klaus R. Dr Veitinger
3/4/5
Director
class O/S missing
27,207 shares
15 Jun 2022
Wilhelm Stahl
3/4/5
EVP, Chief Tech Officer
class O/S missing
21,682 shares
31 Dec 2021
Annie Yoshiyama
3/4/5
Senior VP, Finance and CAO
class O/S missing
14,000 shares
05 Aug 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 28 May 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Tricida, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Klaus R. Dr Veitinger Director Mixed 15 Jun 2022
Sandra I. Coufal Director, 10%+ Owner Mixed 15 Jun 2022
David Hirsch Director Mixed 15 Jun 2022
Mr. Geoffrey Parker COO, CFO and EVP Mixed 28 Feb 2022
David P. Bonita Director, 10%+ Owner Mixed 22 Nov 2022
Wilhelm Stahl EVP, Chief Tech Officer Mixed 31 Dec 2021
Kathryn E. Falberg Director Mixed 15 Jun 2022
Venrock Healthcare Capital Partners II, L.P. 10%+ Owner Mixed 24 Oct 2022
Robert J. Alpern Director Mixed 23 Nov 2022
ORBIMED ADVISORS LLC Director, 10%+ Owner Mixed 22 Nov 2022
Brian M. Isern *possible member of 10% group, 10%+ Owner Mixed 11 Oct 2022
Dawn Parsell Otto EVP, Clinical Development Mixed 28 Feb 2022
Robert McKague EVP, General Counsel Mixed 28 Feb 2022
Annie Yoshiyama Senior VP, Finance and CAO Mixed 05 Aug 2022
Gerrit Klaerner President and CEO, Director Mixed 28 Feb 2022

Recent Insider Transactions by Companies or Individuals for Tricida, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .